Multidrug-resistant gram-negative bacilli were the pathogens commonly found in patients with acute cerebral infarction complicated by diabetes mellitus and nosocomial pulmonary infection.
In a review update, XpertMTB/RIF was found to be sensitive and specific for diagnosing pulmonary TB and rifampicin resistance which is consistent with the last review completed in 2014.
The PCV-13 demonstrated an association with the detection of low-density colonization and resulted in vaccine efficacy against colonization acquisition.
The “Masks Save Lives” campaign is highly effective in preventing nosocomial influenza infection in clinical settings.
The MALDI-TOF assay demonstrated accuracy in the rapid identification of the most commonly isolated strains of bacterial colonies isolated from positive blood cultures.
Histoplasmosis is associated with a wide spectrum of illness and a substantial burden for some patients.
A combination dose of ceftolozane/tazobactam is noninferior to meropenem for treating nosocomial pneumonia.
Data supporting the selection of the antiviral conjugate CB-012 as Cidara Therapeutics Incorporated’s first clinical development candidate from the company’s influenza program.
For prevention of TB in people with HIV, a single month regimen of rifapentine plus isoniazid was noninferior to 9 months of isoniazid alone.